Evaluation of FOXC2 as a candidate gene for chronic progressive lymphedema in draft horses.

The research article discusses an analysis into whether changes in the FOXC2 gene may be responsible for causing Chronic Progressive Lymphedema (CPL), a chronic swelling condition in certain breeds of draft horses. However, the results suggested that, based on the sequence variance of this gene, it is unlikely to be the cause of CPL.

Objective Of The Study

This study aimed to identify if there is any connection between the FOXC2 gene and Chronic Progressive Lymphedema (CPL) in draft horses. The condition is debilitating, often leading to severe discomfort and recurrent secondary infection and sometimes requires euthanasia. Determining a genetic cause would be monumental in facilitating the elimination of this condition.

Methodology

• The research team focused on the FOXC2 gene because mutations in this gene cause a comparable condition in humans, lymphedema-distichiasis.
• The process used to study this involved sequencing the FOXC2 gene in both unaffected and affected draft horses, as well as a control horse.

Findings and Conclusion

• In the process, they found four single nucleotide polymorphisms (or SNPs, which are a type of genetic variation) in the unaffected draft horses and the control horse. This shows that these SNPs were not linked to CPL.
• Upon discovering a fifth SNP in both an affected draft horse and the control horse, the researchers concluded that it, too, was not associated with CPL due to the fact it was not found in all affected horses.
• As a final conclusion, the researchers implied the FOXC2 gene lacks connection with the CPL condition — as none of the SNPs identified were exclusively associated with horses suffering from CPL.

Conclusively, while the research provided more genetic insight into draft horses suffering from CPL, the investigated candidate gene (FOXC2) did not seem to be the likely cause of the condition, requiring more extensive genetic explorations on other candidate genes.